These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 39090109)

  • 1. Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression.
    Jiang Z; Kang Q; Qian H; Xu Z; Tong H; Yang J; Li L; Li R; Li G; Chen F; Lin N; Zhao Y; Shi H; Huang J; Ma X
    Signal Transduct Target Ther; 2024 Aug; 9(1):193. PubMed ID: 39090109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolving the heterogeneous tumour microenvironment in cardiac myxoma through single-cell and spatial transcriptomics.
    Liu X; Shen H; Yu J; Luo F; Li T; Li Q; Yuan X; Sun Y; Zhou Z
    Clin Transl Med; 2024 Feb; 14(2):e1581. PubMed ID: 38318640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review.
    Shafi O; Siddiqui G; Jaffry HA
    BMC Cancer; 2023 Dec; 23(1):1245. PubMed ID: 38110859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy in cardiac myxoma: An important puzzle piece in understanding its inflammatory environment.
    Sramek V; Dridi M; Papoudou-Bai A; Dumollard JM; Péoc'h M; Karpathiou G
    Pathol Res Pract; 2021 Oct; 226():153609. PubMed ID: 34537518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-218 suppresses cardiac myxoma proliferation by targeting myocyte enhancer factor 2D.
    Cao Q; Dong P; Wang Y; Zhang J; Shi X; Wang Y
    Oncol Rep; 2015 May; 33(5):2606-12. PubMed ID: 25812649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10× single-cell sequencing revealed cellular composition heterogeneity in cardiac myxoma with malignant glandular properties.
    Zhang L; Qiu ZH; Wei X; Yao M; Chen SK; He J; Ye JQ; Li YM; Chen LW
    Microvasc Res; 2024 Jul; 154():104697. PubMed ID: 38801942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte-elevated gene-1 mediates insulin-like growth factor 1-induced the progression of cardiac myxoma.
    Fang C; Shen Y; Qi P; Liu Z; Zhang M; Pang X
    Tumour Biol; 2015 Dec; 36(12):9769-77. PubMed ID: 26156800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of cellular components of cardiac myxoma: a light microscopy and immunohistochemistry study.
    Deshpande A; Venugopal P; Kumar AS; Chopra P
    Hum Pathol; 1996 Oct; 27(10):1056-9. PubMed ID: 8892590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence, immune microenvironment, and vascularization in cardiac myxomas.
    Karpathiou G; Dumollard JM; Camy F; Sramek V; Dridi M; Picot T; Mobarki M; Peoc'h M
    Cardiovasc Pathol; 2021; 52():107335. PubMed ID: 33762213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial cardiac myxoma: emphasis on unusual clinical manifestations.
    Powers JC; Falkoff M; Heinle RA; Nanda NC; Ong LS; Weiner RS; Barold SS
    J Thorac Cardiovasc Surg; 1979 May; 77(5):782-8. PubMed ID: 431115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-217 suppresses proliferation and promotes apoptosis in cardiac myxoma by targeting Interleukin-6.
    Zhang J; Wang C; Xu H
    Biochem Biophys Res Commun; 2017 Aug; 490(3):713-718. PubMed ID: 28642131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 plasma levels and tumor size in cardiac myxoma.
    Soeparwata R; Poeml P; Schmid C; Neuhof H; Scheld HH
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1675-7. PubMed ID: 8975864
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiac myxoma--light, electron microscopic and immunocytochemical assessment of histogenesis].
    Tanimura A; Kinoshita T; Nagayama K; Kosuga K
    Gan No Rinsho; 1983 Apr; 29(4):A-21, 325-9. PubMed ID: 6222211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of myocyte enhancer factor 2D in regulating tumor biology of cardiac myxoma.
    Huo Y; Zhao Q; Wang C; Zhao F; Du Y; Sun W
    Tumour Biol; 2016 Apr; 37(4):5405-11. PubMed ID: 26563368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis to identify mRNA markers of cardiac myxoma.
    Skamrov AV; Nechaenko MA; Goryunova LE; Feoktistova ES; Khaspekov GL; Kovalevsky DA; Vinnitsky LI; Sheremeteva GF; Beabealashvilli RSh
    J Mol Cell Cardiol; 2004 Sep; 37(3):717-33. PubMed ID: 15350845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors.
    Kodama H; Hirotani T; Suzuki Y; Ogawa S; Yamazaki K
    Am J Pathol; 2002 Aug; 161(2):381-9. PubMed ID: 12163362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity in cardiac myxomas and its pathological and clinical correlations.
    Di Vito A; Santise G; Mignogna C; Chiefari E; Cardillo G; Presta I; Arturi F; Malara N; Brunetti F; Donato A; Maisano D; Leonetti S; Maselli D; Barni T; Donato G
    Innate Immun; 2018 Jan; 24(1):47-53. PubMed ID: 29145790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent cardiac myxoma in a 25 year old male: a DNA study.
    Marina K; Vasiliki KE; George S; Vasiliki V; Androniki T; Abraham G; Loukas K; Andreas K; Alkiviadis M
    World J Surg Oncol; 2013 Apr; 11():95. PubMed ID: 23618320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric familial cardiac myxoma.
    Akbarzadeh Z; Esmailzadeh M; Yousefi A; Safaei A; Raisi K; Sharifi F
    Eur J Echocardiogr; 2005 Mar; 6(2):148-50. PubMed ID: 15760692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial cardiac myxoma with multiple and contralateral recurrence].
    Ohshima N; Yamada T; Nakahara H; Yokoyama M; Tanabe S; Irie Y; Fujisawa T
    Kyobu Geka; 1990 Dec; 43(13):1060-6. PubMed ID: 2273673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.